NIH SBIR Fast-Track (Omnibus)
Supports United States small businesses with streamlined biomedical pathways from feasibility to continued development.
The NIH SBIR Fast-Track Omnibus is a combined Phase I and Phase II application mechanism that allows U.S. small businesses to submit both phases in a single application reviewed by a single study section. Issued jointly under R43 (Phase I component) and R44 (Phase II component) activity codes, Fast-Track awards cover the full Phase I feasibility period (typically six months, capped at $306,872) foโฆ
Same NIH-mission scope as Phase I and II. Reserved for applicants who already have a fully developed Phase II plan and can defend the entire project trajectory in one application.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see how they score you
Sign up free to see the timeline
Sign up free to see where teams trip up
Guides for this application
All guides โSBIR/STTR Grants for Deeptech Startups
A practical guide to SBIR and STTR grants for deeptech startups, including agency fit, Phase I and II logic, eligibility, budgets, and review criteria.
DocumentsNIH Biosketch Guide: Format, SciENcv Steps, and Examples
Learn what an NIH biosketch is, how the format works, what to prepare for SciENcv, and how startup teams should avoid common biosketch mistakes.
Write proposalHow to Write a Specific Aims Page
Learn how to write a specific aims page for NIH, SBIR-adjacent, and translational R&D grants, with structure, reviewer logic, examples, and common mistakes.
Where to applyGrants for Biotech Startups: NIH, NSF, SBIR/STTR, and Non-Dilutive Funding
A practical guide to grants for biotech startups, including NIH SBIR/STTR, NSF, translational funding, evidence, regulatory readiness, and budgets.
More from NIH
All grants from this funder โDevelopment and Testing of a Multi-use Frameworks Playbook for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI)
๐บ๐ธNIH ยท United States
Funds the design and early validation of frameworks โ guidelines, protocols and standard procedures โ for building and deploying multimodal medical AI reliably.
Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Clinical Centers
๐บ๐ธNIH ยท United States
Funds a clinical centre inside a consortium testing how to use anti-obesity medication in children without harming their growth or mental health.
Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Research Coordinating Center
๐บ๐ธNIH ยท United States
Funds the single centre that runs statistics, data and coordination for the consortium testing anti-obesity medication in children.
Addressing Methodological Challenges with Clinical Trials of Rapid-Acting Psychotropic Interventional Drugs (RAPIDs)
๐บ๐ธNIH ยท United States
Funds work on the methodological problems that make trials of rapid-acting psychotropic drugs hard to interpret, and on sustaining the treatment afterwards.
Assay Validation of High Quality Markers for Clinical Studies in Cancer
๐บ๐ธNIH ยท United States
Funds two years of analytical validation then three of clinical validation for a cancer biomarker assay that already works on human samples.
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3)
๐บ๐ธNIH ยท United States
Funds the clinical validation of a cancer biomarker assay whose analytical performance has already been proven.
Similar grants
Browse the directory โNSF SBIR/STTR Fast-Track Pilot
๐บ๐ธNSF ยท United States
Supports United States deep-tech startups through a combined early and continuation development route.
NCI SBIR/STTR Omnibus (Next Receipt 5)
๐บ๐ธNCI ยท United States
Supports small businesses developing cancer technologies through national NIH collaboration pathways.
NIH SBIR Phase II
๐บ๐ธNIH SEED ยท United States
Supports United States biomedical small businesses advancing successful feasibility work into scale-up development.
NIDDK SBIR/STTR โ Next Opening
๐บ๐ธNIDDK ยท United States
Supports the United States NIDDK small business innovation pathway across metabolic, digestive, and kidney research development.
NIMHD Parent SBIR Grant
๐บ๐ธNIMHD ยท United States
Funds United States small businesses developing health-disparities technologies through NIH SBIR grants.
NSF SBIR Phase II
๐บ๐ธNSF ยท United States
Funds United States deep-tech startups extending proven early projects into substantial technology development.